...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: TNBC no longer active?

Seems like a very non-specific answer to your fair question. As per the response, hopefully we will see a return on our investment in both companies sooner than later. Doesn't appear as  there are any closers in either company. 

Share
New Message
Please login to post a reply